nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
|
Chen, Chung-Hsin |
|
2012 |
30 |
4 |
p. 421-427 7 p. |
artikel |
2 |
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines
|
You, JingJing |
|
2012 |
30 |
4 |
p. 502-508 7 p. |
artikel |
3 |
Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer
|
Saad, Fred |
|
2012 |
30 |
4 |
p. 369-378 10 p. |
artikel |
4 |
CA9 as a molecular marker for differential diagnosis of cystic renal tumors
|
Li, Guorong |
|
2012 |
30 |
4 |
p. 463-468 6 p. |
artikel |
5 |
Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
|
Ellinger, Jörg |
|
2012 |
30 |
4 |
p. 509-515 7 p. |
artikel |
6 |
Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy
|
Drouin, Sarah J. |
|
2012 |
30 |
4 |
p. 402-407 6 p. |
artikel |
7 |
Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer
|
van Rhijn, Bas W.G. |
|
2012 |
30 |
4 |
p. 518-523 6 p. |
artikel |
8 |
Commentary on “A non-cancer-related survival benefit is associated with partial nephrectomy.” Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI, Cancer Prognostics and Health Outcomes Unit, University of Montréal, Health Center, Montreal, Canada
|
Hollenbeck, Brent K. |
|
2012 |
30 |
4 |
p. 543-544 2 p. |
artikel |
9 |
Commentary on “Comparative effectiveness of cryotherapy vs. brachytherapy for localized prostate cancer.” Williams SB, Lei Y, Nguyen PL, Gu X, Lipsitz SR, Yu HY, Kowalczyk KJ, Hu JC, Division of Urologic Surgery, Department of Radiation Oncology, Center for Surgery, Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
|
Hollenbeck, Brent K. |
|
2012 |
30 |
4 |
p. 542-543 2 p. |
artikel |
10 |
Commentary on “Explaining racial differences in prostate cancer mortality.” Taksler GB, Keating NL, Cutler DM, Department of Medicine, New York University School of Medicine, New York, NY
|
Hollenbeck, Brent K. |
|
2012 |
30 |
4 |
p. 542- 1 p. |
artikel |
11 |
Commentary on “Exposure to statins and risk of common cancers: A series of nested case-control studies.” Vinogradova Y, Coupland C, Hippisley-Cox J, Division of Primary Care. University Park, Nottingham, UK
|
Hollenbeck, Brent K. |
|
2012 |
30 |
4 |
p. 544-545 2 p. |
artikel |
12 |
Commentary on “Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.” Pollack CE, Bekelman JE, Epstein AJ, Liao K, Wong YN, Armstrong K, Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD
|
Hollenbeck, Brent K. |
|
2012 |
30 |
4 |
p. 544- 1 p. |
artikel |
13 |
Contents
|
|
|
2012 |
30 |
4 |
p. vi-viii nvt p. |
artikel |
14 |
Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage
|
Augustin, Herbert |
|
2012 |
30 |
4 |
p. 396-401 6 p. |
artikel |
15 |
Editorial Board
|
|
|
2012 |
30 |
4 |
p. v- 1 p. |
artikel |
16 |
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study
|
Friedlander, Terence W. |
|
2012 |
30 |
4 |
p. 408-414 7 p. |
artikel |
17 |
Elementary studies on elevated steroidogenic factor-1 expression in aldosterone-producing adenoma
|
Hu, Dongliang |
|
2012 |
30 |
4 |
p. 457-462 6 p. |
artikel |
18 |
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer
|
Chiyomaru, Takeshi |
|
2012 |
30 |
4 |
p. 434-443 10 p. |
artikel |
19 |
Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities
|
Chang, David W. |
|
2012 |
30 |
4 |
p. 524-532 9 p. |
artikel |
20 |
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder
|
Wang, Hang |
|
2012 |
30 |
4 |
p. 428-433 6 p. |
artikel |
21 |
Information for Authors
|
|
|
2012 |
30 |
4 |
p. IBC- 1 p. |
artikel |
22 |
Kidney function following nephrectomy: Similitude and discrepancies between kidney cancer and living donation
|
Timsit, Marc-Olivier |
|
2012 |
30 |
4 |
p. 482-486 5 p. |
artikel |
23 |
Marital status independently predicts testis cancer survival—an analysis of the SEER database
|
Abern, Michael R. |
|
2012 |
30 |
4 |
p. 487-493 7 p. |
artikel |
24 |
Masthead
|
|
|
2012 |
30 |
4 |
p. iv- 1 p. |
artikel |
25 |
mTOR pathway inhibition in renal cell carcinoma
|
Pinto Marín, Alvaro |
|
2012 |
30 |
4 |
p. 356-361 6 p. |
artikel |
26 |
New technologies and techniques for laparoscopic partial nephrectomy
|
Wolf Jr., J. Stuart |
|
2012 |
30 |
4 |
p. 353-355 3 p. |
artikel |
27 |
Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients
|
Che, Xiangyu |
|
2012 |
30 |
4 |
p. 450-456 7 p. |
artikel |
28 |
Paraffin-embedded tissue is less accurate than frozen section analysis for determining VHL mutational status in sporadic renal cell carcinoma
|
Verhoest, Grégory |
|
2012 |
30 |
4 |
p. 469-475 7 p. |
artikel |
29 |
Predicting biopsy-proven prostate cancer recurrence following cryosurgery
|
Caso, Jorge R. |
|
2012 |
30 |
4 |
p. 391-395 5 p. |
artikel |
30 |
Prognostic influence of the third Gleason grade in prostatectomy specimens
|
Cedeño Díaz, Oderay Mabel |
|
2012 |
30 |
4 |
p. 386-390 5 p. |
artikel |
31 |
Prognostic markers for urothelial cancer: Obstacles and opportunities
|
Malmström, Per-Uno |
|
2012 |
30 |
4 |
p. 516-517 2 p. |
artikel |
32 |
Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planning
|
Matzkin, Haim |
|
2012 |
30 |
4 |
p. 379-385 7 p. |
artikel |
33 |
Recurrent seminomas: Clinical features and biologic implications
|
Som, Avik |
|
2012 |
30 |
4 |
p. 494-501 8 p. |
artikel |
34 |
Renal cell carcinoma with metastases to the gallbladder: Four cases from the National Cancer Institute (NCI) and review of the literature
|
Chung, Paul H. |
|
2012 |
30 |
4 |
p. 476-481 6 p. |
artikel |
35 |
Renal oncocytoma—are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis
|
Haifler, Miki |
|
2012 |
30 |
4 |
p. 362-368 7 p. |
artikel |
36 |
Stress-activated kinase pathway alteration is a frequent event in bladder cancer
|
Otto, Kristen B. |
|
2012 |
30 |
4 |
p. 415-420 6 p. |
artikel |
37 |
Survey Section Editorial Board
|
|
|
2012 |
30 |
4 |
p. 541- 1 p. |
artikel |
38 |
The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles
|
Höglund, Mattias |
|
2012 |
30 |
4 |
p. 533-540 8 p. |
artikel |
39 |
Up-regulation of glucosylceramide synthase in urinary bladder neoplasms
|
Sun, Chang-cheng |
|
2012 |
30 |
4 |
p. 444-449 6 p. |
artikel |
40 |
Will identification of a prostate cancer stem cell lead to its cure?
|
Garraway, Isla P. |
|
2012 |
30 |
4 |
p. 351-352 2 p. |
artikel |